Insider trade

CEO sold ~$2.43M of DGX shares in the open market

Traded Sep 1, 2026 · Filed Sep 3, 2026

Quest DiagnosticsDGX

~$2.43M
Reported value · 10K sh @ $242.72: 122K
Holds after · shares reported: -2.2%
stock since the trade · S&P 500 +0.3%, $236.22 → $231.09 on Oct 1

Why it stands out

The boss of Quest Diagnostics sold $2.43M of Quest Diagnostics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 1, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 3, 2026

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,427,200

Shares × reported transaction price

Timing vs results

40 days after results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $236.22 on Sep 1, 2026, within 4% of its 52-week high, after a 14% rise over the previous 30 trading days

52-week range $173.49 (Jan 5, 2026) to $245.00 (Aug 26, 2026), 88% of the way up, from 252 adjusted closes. 30 trading days earlier: $206.84 on Jul 21, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.9%	-0.8%	-0.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0001599837-26-000007
Filed / recorded: Sep 3, 2026, 9:05 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: QUEST DIAGNOSTICS INC
Issuer CIK: 1022079
Ticker: DGX
Reporting person: J. E. Davis
Relationship: Director, Officer
Officer title: CEO and President
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Sep 1, 2026
Transaction code: S
Shares / units: 10,000
Price per share: $242.72
Acquired / disposed: Disposed (D)
Shares owned after: 122,423
Ownership form: Direct
Amendment: No

Footnotes from the filing

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Around the same time

2d ago

135Derivative units

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

5w ago

23KShares · @ $112.17

Derivative exercise or conversion — not an open-market buy.